Krastev Z
Clinic of Gastroenterology, University Hospital St. Ivan Rilsky, Medical University, Sofia.
Hepatogastroenterology. 1998 Jan-Feb;45(19):160-9.
BACKGROUND/AIMS: Many hepatologists believe that the Child's classification is not the ultimate prognostic tool for liver disease. Our aim was to develop an index for the estimation of the severity of liver damage, to evaluate its predictive power for the short-term and long-term prognosis of patients with chronic liver disease, and for the estimation of the effect of different therapeutic regimens.
The Liver Damage Score (LDS) was developed based on the analysis of the laboratory data of 151 randomly selected patients with liver diseases. Variables for reduced protein synthesis, increased production of antibodies, cytolysis, cholestasis, functional renal failure were combined into LDS according to the results of cluster analysis. The evaluation of the liver injury was analyzed in 696 patients with different liver diseases.
There are three groups of liver diseases: mild-with LDS of 1-2 U, moderate with LDS 3-4.5 U and severe with LDS > 5.0 U. There was a good correlation between the LDS and the scores for liver cirrhosis. Values above 4-6 U carry bad prognosis. The LDS truthfully reflects the evolution of liver diseases over time and the effect of therapy.
The LDS is a new, simple, low-cost, biomathematically and pathophysiologically based index, useful for monitoring practically all patients with liver diseases, no matter what the etiology and stage of the liver injury is. It allows a quantitative expression of the disease severity and the improvement or deterioration in its course.
背景/目的:许多肝病学家认为,Child分级并非肝病最终的预后评估工具。我们的目的是开发一种用于评估肝损伤严重程度的指数,以评估其对慢性肝病患者短期和长期预后的预测能力,以及评估不同治疗方案的效果。
基于对151例随机选取的肝病患者实验室数据的分析,制定了肝损伤评分(LDS)。根据聚类分析结果,将蛋白质合成减少、抗体产生增加、细胞溶解、胆汁淤积、功能性肾衰竭等变量纳入LDS。对696例不同肝病患者的肝损伤情况进行了评估。
肝病分为三组:轻度——LDS为1 - 2 U;中度——LDS为3 - 4.5 U;重度——LDS > 5.0 U。LDS与肝硬化评分之间存在良好的相关性。4 - 6 U以上的数值提示预后不良。LDS真实反映了肝病随时间的演变以及治疗效果。
LDS是一种新的、简单、低成本、基于生物数学和病理生理学的指数,可用于监测几乎所有肝病患者,无论肝损伤的病因和阶段如何。它能够对疾病严重程度及其病程中的改善或恶化进行定量表达。